PRPH Competitors & Alternatives
Compare ProPhase Labs Inc with similar stocks in the same industry
Diagnostics & Research
PRPH
Main Stock$0.36
Tradestie Score
56
Market Cap
$21.41M
Revenue Growth
-0.4%
Analyst Upside
+3705.8%
Top Competitors
40 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CDNA
CareDx, Inc.
|
$28.63
|
$798.40M | - | 60 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$20.80
|
$719.31M | - | 61 | Compare |
|
MYGN
Myriad Genetics Inc
|
$6.06
|
$719.23M | - | 55 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$24.52
|
$667.77M | - | 61 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$14.79
|
$612.76M | - | 57 | Compare |
|
ICCC
Immucell Corp
|
$11.40
|
$59.70M | - | 60 | Compare |
|
CPIX
Cumberland Pharmaceuticals Inc
|
$6.07
|
$46.68M | - | 56 | Compare |
|
NAII
Natural Alternatives International Inc.
|
$2.25
|
$17.91M | - | 54 | Compare |
|
XTLB
XTL Biopharmaceuticals Ltd. American Depositary Shares
|
$2.88
|
$10.14M | - | 52 | Compare |
|
SNOA
Sonoma Pharmaceuticals, Inc. Common Stock
|
$1.29
|
$6.37M | - | 53 | Compare |
More PRPH Analysis
Data updated: Jul 09, 2026 | Industry: Diagnostics & Research (SIC 2834)
40 stocks in this industry